{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:07:30Z","timestamp":1747660050668,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cervical cancer is often associated with malignant ureteral obstruction and consequent hydronephrosis. Hydronephrosis caused in this way can be resolved by placing ureteral stents or performing a percutaneous nephrostomy. Complications that may occur during the retrograde ureteral stent placement are usually mild, but serious complications such as stent migration into the cardiovascular system are also possible. Here we present an unusual case where a ureteral stent entered the abdominal aorta during the cystoscopic ureteral stenting, which was resolved by a cystoscopic stent removal kept in check by endovascular catheters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>The 48-year-old female patient was treated in the regional secondary healthcare facility due to bilateral hydronephrosis caused by cervical cancer. The patient had bilateral percutaneous nephrostomies and ureteral stents. Due to the calcification of the left ureteral stent, an urethrorenoscopy with lithotripsy of the calculus in the left ureter was performed in the regional secondary healthcare facility, and the ureteral stent was cystoscopically replaced. The control radiography of the urinary tract showed a misplacement of the left ureteral stent, and a computed tomography showed that the stent was located in the abdominal aorta. The patient was referred to the University Clinical Center of Serbia, where a ureteral stent was cystoscopically removed from the abdominal aorta under the control of endovascular catheters. The patient was in good general condition at all times, with no signs of bleeding, and she was discharged from the hospital on the fourth postoperative day.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The migration of a ureteral stent into the abdominal aorta and the cardiovascular system in general is a rare type of ureteral stenting complication whose treatment requires a multidisciplinary approach. In order to prevent such complications, it is necessary to strictly adhere to the indications for the ureteral stent placement in the case of malignant ureteral obstruction. Also, this procedure should be performed according to the current guidelines and controlled by an X-ray or ultrasound.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-022-02049-6","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:03:05Z","timestamp":1668772985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A misplacement of a ureteral stent into the abdominal aorta: a case report of a rare retrograde ureteral stenting complication"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5268-5801","authenticated-orcid":false,"given":"Nebojsa","family":"Prijovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Cegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Cvetic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veljko","family":"Santric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branko","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovan","family":"Radojevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"key":"2049_CR1","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00520-014-2482-y","volume":"23","author":"K Patel","year":"2015","unstructured":"Patel K, Foster NR, Kumar A, et al. Hydronephrosis in patients with cervical cancer: an assessment of morbidity and survival. Support Care Cancer. 2015;23:1303\u20139.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2049_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/IGC.0b013e318243b475","volume":"22","author":"Y Song","year":"2012","unstructured":"Song Y, Fei X, Song Y. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies. Int J Gynecol Cancer. 2012;22(4):697\u2013702. https:\/\/doi.org\/10.1097\/IGC.0b013e318243b475 PMID: 22315095.","journal-title":"Int J Gynecol Cancer"},{"key":"2049_CR3","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/01.ju.0000181807.56114.b7","volume":"174","author":"AM Ganatra","year":"2005","unstructured":"Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol. 2005;174:2125\u20138.","journal-title":"J Urol"},{"issue":"2\u20133","key":"2049_CR4","first-page":"e147","volume":"12","author":"Y Ahallal","year":"2010","unstructured":"Ahallal Y, Khallouk A, El Fassi MJ, Farih MH. Risk factor analysis and management of ureteral double-j stent complications. Rev Urol. 2010 Spring;12(2\u20133):e147\u201351.","journal-title":"Rev Urol"},{"key":"2049_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.12998\/wjcc.v6.i16.1160","volume":"6","author":"XW Mao","year":"2018","unstructured":"Mao XW, Xu G, Xiao JQ, et al. Ureteral double J stent displaced into vena cava and management with laparoscopy: a case report and review of the literature. World J Clin Cases. 2018;6:1160\u20133.","journal-title":"World J Clin Cases"},{"key":"2049_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4103\/0970-1591.120125","volume":"29","author":"RB Sabnis","year":"2013","unstructured":"Sabnis RB, Ganpule AP, Ganpule SA. Migration of double J stent into the inferior vena cava and the right atrium. Indian J Urol. 2013;29:353\u20134.","journal-title":"Indian J Urol"},{"key":"2049_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/end.2011.0469","volume":"26","author":"S Falahatkar","year":"2012","unstructured":"Falahatkar S, Hemmati H, Gholamjani MK. Intracaval migration: an uncommon complication of ureteral double-J stent placement. J Endourol. 2012;26:119\u201321.","journal-title":"J Endourol"},{"key":"2049_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12905-021-01405-2","volume":"21","author":"YH Chen","year":"2021","unstructured":"Chen YH, Chen M, Chen YH. Intrathoracic ureteric stent migration through a Reno-pleural fistula: a case report of rare antegrade ureteric stenting complication. BMC Womens Health. 2021;21:270.","journal-title":"BMC Womens Health"},{"issue":"6","key":"2049_CR9","doi-asserted-by":"publisher","first-page":"e24182","DOI":"10.1097\/MD.0000000000024182","volume":"100","author":"Y-R Yang","year":"2021","unstructured":"Yang Y-R, Chen S-J, Yen P-Y, Huang C-P, Chiu L-T, Lin W-C, Chen H-Y, Chen Y-H, Chen W-C. Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: a nationwide population-based retrospective cohort study. Medicine. 2021;100(6):e24182.","journal-title":"Medicine"},{"key":"2049_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.juro.2007.03.026","volume":"178","author":"LM Wong","year":"2007","unstructured":"Wong LM, Cleeve LK, Milner AD, et al. Malignant ureteral obstruction: outcomes after intervention. Have things changed? J Urol. 2007;178:178\u201383.","journal-title":"J Urol"},{"key":"2049_CR11","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.urology.2004.06.029","volume":"64","author":"JH Ku","year":"2004","unstructured":"Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology. 2004;64:895\u20139.","journal-title":"Urology."},{"key":"2049_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00120-016-0253-8","volume":"55","author":"C Netsch","year":"2016","unstructured":"Netsch C, Becker B, Gross AJ. Therapie der Harnleiterobstruktion : Stellenwert von perkutaner Nephrostomie und von Harnleiterschienen [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents]. Urologe A. 2016;55:1497\u2013510.","journal-title":"Urologe A"},{"key":"2049_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1159\/000052529","volume":"39","author":"HB Joshi","year":"2001","unstructured":"Joshi HB, Adams S, Obadeyi OO, Rao PN. Nephrostomy tube or 'JJ' ureteric stent in ureteric obstruction: assessment of patient perspectives using quality-of-life survey and utility analysis. Eur Urol. 2001;39:695\u2013701.","journal-title":"Eur Urol"},{"key":"2049_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.urology.2008.01.046","volume":"72","author":"ES Hyams","year":"2008","unstructured":"Hyams ES, Shah O. Malignant extrinsic ureteral obstruction: a survey of urologists and medical oncologists regarding treatment patterns and preferences. Urology. 2008;72:51\u20136.","journal-title":"Urology"},{"key":"2049_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0022-5347(17)56643-4","volume":"121","author":"TW Hepperlen","year":"1979","unstructured":"Hepperlen TW, Mardis HK, Kammandel H. The pigtail ureteral stent in the cancer patient. J Urol. 1979;121:17\u20138.","journal-title":"J Urol"},{"key":"2049_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/iju.14119","volume":"27","author":"GM Sali","year":"2020","unstructured":"Sali GM, Joshi HB. Ureteric stents: overview of current clinical applications and economic implications. Int J Urol. 2020;27:7\u201315.","journal-title":"Int J Urol"},{"key":"2049_CR17","doi-asserted-by":"publisher","first-page":"e36527","DOI":"10.5812\/numonthly.36527","volume":"8","author":"D Arab","year":"2016","unstructured":"Arab D, Ardestani ZA, Eskandarian R, et al. An extremely rare complication of ureteral pigtail stent placement: a case report. Nephrourol Mon. 2016;8:e36527.","journal-title":"Nephrourol Mon"},{"key":"2049_CR18","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.urology.2020.07.007","volume":"144","author":"D Wang","year":"2020","unstructured":"Wang D, Sun H, Yang C, Ding D, Qian W, Yu D. Management of a Ureteral Stent Displaced into the abdominal aorta: a case report. Urology. 2020;144:e10\u20134.","journal-title":"Urology"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-02049-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-02049-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:05:18Z","timestamp":1668773118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-02049-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2049"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-02049-6","relation":{},"ISSN":["1472-6874"],"issn-type":[{"type":"electronic","value":"1472-6874"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this manuscript and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"458"}}